Trial Profile
The Protective Effect of Thymosin Alpha 1 (Zadaxin) for Small Hepatocellular Carcinoma from Recurrence/Metastasis Following Radical Resection: A Randomised Controlled Prospective Study.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2010
Price :
$35
*
At a glance
- Drugs Thymalfasin (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 23 Nov 2009 New trial record